Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insmed (INSM) Liabilities and Shareholders Equity (2016 - 2026)

Insmed's Liabilities and Shareholders Equity history spans 17 years, with the latest figure at $2.1 billion for Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 15.15% to $2.1 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $9.2 billion through Mar 2026, up 19.37% year-over-year, with the annual reading at $2.3 billion for FY2025, 11.82% up from the prior year.
  • Liabilities and Shareholders Equity came in at $2.1 billion for Q1 2026, down from $2.3 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.5 billion in Q2 2025 to a low of $994.8 million in Q3 2022.
  • The 5-year median for Liabilities and Shareholders Equity is $1.7 billion (2022), against an average of $1.7 billion.
  • The largest YoY upside for Liabilities and Shareholders Equity was 66.57% in 2022 against a maximum downside of 24.16% in 2022.
  • Insmed's Liabilities and Shareholders Equity stood at $1.7 billion in 2022, then fell by 19.72% to $1.3 billion in 2023, then skyrocketed by 52.29% to $2.0 billion in 2024, then increased by 11.82% to $2.3 billion in 2025, then dropped by 8.33% to $2.1 billion in 2026.
  • Per Business Quant, the three most recent readings for INSM's Liabilities and Shareholders Equity are $2.1 billion (Q1 2026), $2.3 billion (Q4 2025), and $2.4 billion (Q3 2025).